Defence Therapeutics Inc.
DTC
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -510.40K | -837.30K | -663.30K | -575.00K | -444.90K |
| Total Depreciation and Amortization | 11.80K | 13.90K | 12.30K | 12.70K | 13.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 136.20K | 175.60K | 243.50K | 189.30K | 130.70K |
| Change in Net Operating Assets | -160.80K | 52.70K | -983.30K | -104.50K | 365.40K |
| Cash from Operations | -523.20K | -595.10K | -1.39M | -477.50K | 64.10K |
| Capital Expenditure | -15.30K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -10.80K | 0.00 | 13.30K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -15.30K | -10.80K | 0.00 | 13.30K | -- |
| Total Debt Issued | 2.00M | 0.00 | 0.00 | 0.00 | 15.00K |
| Total Debt Repaid | -15.10K | -3.30K | -22.50K | -129.50K | -27.80K |
| Issuance of Common Stock | -- | 0.00 | 4.22M | 800.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -160.10K | -6.90K | -247.40K | -21.40K | -- |
| Cash from Financing | 1.32M | -7.40K | 2.75M | 463.70K | -9.40K |
| Foreign Exchange rate Adjustments | 4.00K | 900.00 | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | 0.00 | -- | -- |
| Net Change in Cash | 790.30K | -612.40K | 1.36M | -500.00 | 54.70K |